Therefore, we hypothesized that the observed variations in the transcription factor FOXP3 gene may affect the risk of T2DM and T2DN by indirectly altering the function of FOXP3 and/or its expression. This evidence concerns the gene FOXP3 and type 2 diabetes mellitus.